117 related articles for article (PubMed ID: 29250796)
1. XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability.
Yu Y; Jin H; Xu J; Gu J; Li X; Xie Q; Huang H; Li J; Tian Z; Jiang G; Chen C; He F; Wu XR; Huang C
Int J Cancer; 2018 May; 142(10):2040-2055. PubMed ID: 29250796
[TBL] [Abstract][Full Text] [Related]
2. Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure.
Hua X; Zou R; Bai X; Yang Y; Lu J; Huang C
BMC Biol; 2023 Aug; 21(1):181. PubMed ID: 37635218
[TBL] [Abstract][Full Text] [Related]
3. RhoGDIβ inhibition via miR-200c/AUF1/SOX2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
Yang Y; Tian Z; He L; Meng H; Xie X; Yang Z; Wang X; Zhao Y; Huang C
Mol Carcinog; 2024 May; 63(5):977-990. PubMed ID: 38376344
[TBL] [Abstract][Full Text] [Related]
4. NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein.
Zhu J; Li Y; Chen C; Ma J; Sun W; Tian Z; Li J; Xu J; Liu CS; Zhang D; Huang C; Huang H
Neoplasia; 2017 Sep; 19(9):672-683. PubMed ID: 28772241
[TBL] [Abstract][Full Text] [Related]
5. XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell.
Huang C; Zeng X; Jiang G; Liao X; Liu C; Li J; Jin H; Zhu J; Sun H; Wu XR; Huang C
J Hematol Oncol; 2017 Jan; 10(1):6. PubMed ID: 28057023
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemic Stress Induces Expression, Degradation, and Nuclear Association of Rho GDP Dissociation Inhibitor 2 (RhoGDIβ) in Pancreatic β-Cells.
Gleason N; Kowluru A
Cells; 2024 Feb; 13(3):. PubMed ID: 38334664
[TBL] [Abstract][Full Text] [Related]
7. ISO, via Upregulating MiR-137 Transcription, Inhibits GSK3β-HSP70-MMP-2 Axis, Resulting in Attenuating Urothelial Cancer Invasion.
Guo X; Huang H; Jin H; Xu J; Risal S; Li J; Li X; Yan H; Zeng X; Xue L; Chen C; Huang C
Mol Ther Nucleic Acids; 2018 Sep; 12():337-349. PubMed ID: 30195772
[TBL] [Abstract][Full Text] [Related]
8. Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamics.
Wang X; Liu J; Azoitei A; Eiseler T; Meessen S; Jiang W; Zheng X; Makori AW; Eckstein M; Hartmann A; Stilgenbauer S; Elati M; Hohwieler M; Kleger A; John A; Zengerling F; Wezel F; Bolenz C; Günes C
Cell Mol Life Sci; 2023 Sep; 80(10):299. PubMed ID: 37740130
[TBL] [Abstract][Full Text] [Related]
9. XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion.
Xu J; Hua X; Yang R; Jin H; Li J; Zhu J; Tian Z; Huang M; Jiang G; Huang H; Huang C
Oncogenesis; 2019 Dec; 8(12):71. PubMed ID: 31811115
[TBL] [Abstract][Full Text] [Related]
10. ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis.
Zhu J; Li Y; Tian Z; Hua X; Gu J; Li J; Liu C; Jin H; Wang Y; Jiang G; Huang H; Huang C
Mol Ther Nucleic Acids; 2017 Jun; 7():299-313. PubMed ID: 28624205
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer.
Jin H; Xue L; Mo L; Zhang D; Guo X; Xu J; Li J; Peng M; Zhao X; Zhong M; Xu D; Wu XR; Huang H; Huang C
Cell Adh Migr; 2019 Dec; 13(1):236-248. PubMed ID: 31240993
[TBL] [Abstract][Full Text] [Related]
12. The novel microRNA hsa-miR-CHA1 regulates cell proliferation and apoptosis in human lung cancer by targeting XIAP.
Yoo JK; Lee JM; Kang SH; Jeon SH; Kim CM; Oh SH; Kim CH; Kim NK; Kim JK
Lung Cancer; 2019 Jun; 132():99-106. PubMed ID: 31097102
[TBL] [Abstract][Full Text] [Related]
13. Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
Zhao Y; Li M; Wu W; Miao W; Liu H
Front Immunol; 2023; 14():1161273. PubMed ID: 37090731
[TBL] [Abstract][Full Text] [Related]
14. Major pathways involved in macrophage polarization in cancer.
Kerneur C; Cano CE; Olive D
Front Immunol; 2022; 13():1026954. PubMed ID: 36325334
[TBL] [Abstract][Full Text] [Related]
15. Effects of Metabolism on Macrophage Polarization Under Different Disease Backgrounds.
Sun JX; Xu XH; Jin L
Front Immunol; 2022; 13():880286. PubMed ID: 35911719
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment.
Wang S; Liu G; Li Y; Pan Y
Front Immunol; 2022; 13():840029. PubMed ID: 35874739
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44.
Wang W; Zhang M; Huang Z; Wang L; Yue Y; Wang X; Lu S; Fan J
Anticancer Drugs; 2022 Jan; 33(1):e103-e112. PubMed ID: 34407043
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs).
Dymicka-Piekarska V; Koper-Lenkiewicz OM; Zińczuk J; Kratz E; Kamińska J
Cancer Immunol Immunother; 2021 Jun; 70(6):1497-1510. PubMed ID: 33146401
[TBL] [Abstract][Full Text] [Related]
19. FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy.
Im JH; Buzzelli JN; Jones K; Franchini F; Gordon-Weeks A; Markelc B; Chen J; Kim J; Cao Y; Muschel RJ
Nat Commun; 2020 Aug; 11(1):4064. PubMed ID: 32792542
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
Guo CC; Majewski T; Zhang L; Yao H; Bondaruk J; Wang Y; Zhang S; Wang Z; Lee JG; Lee S; Cogdell D; Zhang M; Wei P; Grossman HB; Kamat A; Duplisea JJ; Ferguson JE; Huang H; Dadhania V; Gao J; Dinney C; Weinstein JN; Baggerly K; McConkey D; Czerniak B
Cell Rep; 2019 May; 27(6):1781-1793.e4. PubMed ID: 31067463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
